ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

O’Leary Leads RPCI’s OR;

February 8, 2002

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Larynx Preservation Provides Better Voice Quality For Patients

February 29, 2008

Also in this 8-page issue: NCI contract will keep Cancer Genetics Network database alive, but center grants will not be recompeted.

July 23, 2004

ARRA Funding Announcements Listed

April 10, 2009